2017 Gastro-Intestinal Stromal Tumors Pipeline Highlights Update - ResearchAndMarkets.com

DUBLIN--()--The "Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2017 Update" drug pipelines has been added to ResearchAndMarkets.com's offering.

Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2017 Update, provides the most up-to-date information on key pipeline products in the global Gastro-Intestinal Stromal Tumors market.

It covers emerging therapies for Gastro-Intestinal Stromal Tumors in active clinical development stages, including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Gastro-Intestinal Stromal Tumors pipeline products by clinical trial stages, including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Gastro-Intestinal Stromal Tumors pipeline products by their dominant mechanism of action. This helps executives to categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Gastro-Intestinal Stromal Tumors pipeline products by the company.

Short-term Launch Highlights:

Find out which Gastro-Intestinal Stromal Tumors pipeline products will be launched in the US and ex-US till 2020.

Summary:

  • Gastro-Intestinal Stromal Tumors phase 3 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors phase 2 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors phase 1 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors preclinical research pipeline products
  • Gastro-Intestinal Stromal Tumors discovery stage pipeline products
  • Gastro-Intestinal Stromal Tumors pipeline products short-term launch highlights

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/xtgpkl/2017?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs